| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44249903P | 2003-01-24 | 2003-01-24 | |
| PCT/US2004/001848WO2004066983A2 (en) | 2003-01-24 | 2004-01-23 | Controlled release of highly soluble agents |
| Publication Number | Publication Date |
|---|---|
| MXPA05007717Atrue MXPA05007717A (es) | 2005-09-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05007717AMXPA05007717A (es) | 2003-01-24 | 2004-01-23 | Liberacion controlada de agentes altamente solubles. |
| Country | Link |
|---|---|
| US (1) | US20040175426A1 (es) |
| EP (1) | EP1592411A2 (es) |
| JP (1) | JP2006516621A (es) |
| KR (1) | KR20050123091A (es) |
| CN (3) | CN1741793A (es) |
| AR (1) | AR042920A1 (es) |
| AU (1) | AU2004207523A1 (es) |
| BR (1) | BRPI0406858A (es) |
| CA (1) | CA2513884A1 (es) |
| MX (1) | MXPA05007717A (es) |
| TW (1) | TW200509998A (es) |
| WO (1) | WO2004066983A2 (es) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005000278A1 (en)* | 2003-06-26 | 2005-01-06 | Mediolanum Pharmaceuticals Ltd. | Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof |
| TWI357815B (en)* | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
| US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| US20070129402A1 (en)* | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
| US20060246003A1 (en)* | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| AU2005320547B2 (en) | 2004-12-27 | 2009-02-05 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20090023778A1 (en)* | 2005-04-28 | 2009-01-22 | Eisai R&D Management Co., Ltd. | Composition Containing Anti-Dementia Drug |
| RU2008104638A (ru) | 2005-07-07 | 2009-08-20 | Фарнэм Компаниз, Инк. (Us) | Фармацевтические композиции хорошо растворимых в воде лекарственных средств, обеспечивающих их замедленное высвобождение |
| WO2008039995A2 (en)* | 2006-09-28 | 2008-04-03 | Vance Products Incorporated, D/Ba Cook Urological Incorporated | Medical device including a bioactive in a non-ionic and an ionic form and methods of preparation thereof |
| US20080081829A1 (en)* | 2006-09-28 | 2008-04-03 | Med Institute, Inc | Medical Device Including an Anesthetic and Method of Preparation Thereof |
| UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| US8232531B2 (en)* | 2007-03-29 | 2012-07-31 | Varian Medical Systems, Inc. | Corrosion barrier layer for photoconductive X-ray imagers |
| CN101053680B (zh)* | 2007-05-23 | 2010-06-16 | 刘红玲 | 防治后发障形成的具抗增殖药涂层的人工晶体 |
| CN102112076B (zh)* | 2007-09-07 | 2015-04-22 | 马缇医疗股份有限公司 | 泪腺植入物及相关方法 |
| FR2926467B1 (fr)* | 2008-01-23 | 2011-01-21 | Univ Lille Sciences Tech | Prothese vasculaire impermeable et procede de preparation de ladite prothese |
| EP2481399B1 (en) | 2009-08-18 | 2015-11-25 | Tohoku University | Sustained drug delivery system |
| WO2011127064A2 (en)* | 2010-04-06 | 2011-10-13 | Allergan, Inc. | Sustained-release reservoir implants for intracameral drug delivery |
| KR102272235B1 (ko)* | 2016-05-12 | 2021-07-01 | 머크 샤프 앤드 돔 코포레이션 | 항바이러스제의 전달을 위한 약물 전달 시스템 |
| CN117069622A (zh)* | 2016-11-09 | 2023-11-17 | 诺沃梅迪科斯有限公司 | 1,1-二甲双胍的亚硝酸盐、药物组合物和使用方法 |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898733A (en)* | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
| US5141752A (en)* | 1986-05-09 | 1992-08-25 | Alza Corporation | Delayed drug delivery device |
| US4994273A (en)* | 1987-11-02 | 1991-02-19 | Merck & Co., Inc. | Solubility modulated drug delivery device |
| US5098443A (en)* | 1989-03-23 | 1992-03-24 | University Of Miami | Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
| US5378475A (en)* | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5773019A (en)* | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5902598A (en)* | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6375972B1 (en)* | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| Publication number | Publication date |
|---|---|
| CN1756537A (zh) | 2006-04-05 |
| EP1592411A2 (en) | 2005-11-09 |
| JP2006516621A (ja) | 2006-07-06 |
| AR042920A1 (es) | 2005-07-06 |
| KR20050123091A (ko) | 2005-12-29 |
| BRPI0406858A (pt) | 2006-01-03 |
| US20040175426A1 (en) | 2004-09-09 |
| WO2004066983A2 (en) | 2004-08-12 |
| CN1741792A (zh) | 2006-03-01 |
| TW200509998A (en) | 2005-03-16 |
| CN1741793A (zh) | 2006-03-01 |
| WO2004066983A3 (en) | 2004-11-18 |
| AU2004207523A1 (en) | 2004-08-12 |
| CA2513884A1 (en) | 2004-08-12 |
| CN100594899C (zh) | 2010-03-24 |
| Publication | Publication Date | Title |
|---|---|---|
| TW200509998A (en) | Controlled release of highly soluble agents | |
| IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
| MXPA05002814A (es) | Formulacion para agentes lipofilicos. | |
| WO2004087011A3 (en) | Therapeutic agent delivery device with controlled therapeutic agent release rates | |
| MY167123A (en) | Conveniently implantable sustained release drug compositions | |
| WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
| WO2003002069A3 (en) | Intradermal delivery of vaccines and gene therapeutic agents via microcannula | |
| PL366430A1 (en) | Sustained release formulations of oxymorphone | |
| WO2005120461A3 (en) | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof | |
| TW200505402A (en) | Ophthalmic drug delivery device | |
| WO2005107726A3 (en) | Method for the treatment of back pain | |
| MXPA03007837A (es) | Composiciones para suministrar bisfosfonatos. | |
| WO2002013873A3 (en) | P97-active agent conjugates and their methods of use | |
| WO2006037106A3 (en) | Carboxy-amido-triazoles for the localized treatment of ocular diseases | |
| WO2004112711A3 (en) | Oral extended-release composition | |
| WO2004096151A3 (en) | Methods and devices for the sustained release of multiple drugs | |
| PL373567A1 (en) | Conjugates of therapeutic or cytotoxic agents and biologically active peptides | |
| AU7315301A (en) | Compounds and compositions for delivering active agents | |
| MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
| HUP9902076A2 (hu) | Szexuális rendellenességek kezelésére alkalmas intranazális készítmény | |
| NO20062504L (no) | Sammensetninger og doseringsformer for forbedret absorpsjon | |
| TW200642704A (en) | Oral drug delivery system and methods of use thereof | |
| WO2005007117A3 (en) | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders | |
| MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
| MX347237B (es) | Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina. |